Search

Your search keyword '"Patrick Dumont"' showing total 201 results

Search Constraints

Start Over You searched for: Author "Patrick Dumont" Remove constraint Author: "Patrick Dumont"
201 results on '"Patrick Dumont"'

Search Results

101. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

102. Belgium

103. Stress-Induced Premature Senescence or Stress-Induced Senescence-Like Phenotype: OneIn VivoReality, Two Possible Definitions?

104. [Untitled]

105. IFCT-GFPC-1101 trial: A multicenter phase III assessing a maintenance strategy determined by response to induction chemotherapy compared to continuation maintenance with pemetrexed in patients (pts) with advanced non-squamous (NSQ) NSCLC

106. P1.01-038 Prognosis Value of Body Mass Index (BMI) and Weight Loss at Diagnosis in Primary Lung Cancer: Results of KBP-2010-CPHG Study

110. Belgium

111. Growth kinetics rather than stress accelerate telomere shortening in cultures of human diploid fibroblasts in oxidative stress-induced premature senescence

112. Parliamentary Elites in Central and Eastern Europe

113. [Untitled]

114. The regulatory status of the Ka-band

115. Loss of a Negative Feedback Loop Involving Pea3 and Cyclin D2 Is Required for Pea3-Induced Migration in Transformed Mammary Epithelial Cells

116. Low earth orbit mobile communication satellite systems: A two-year history since WARC-92

117. Nucleoside Analogs. 14. The Synthesis and Antitumor Activity in Mice of Molecular Combinations of 5-Fluorouracil and N-(2-Chloroethyl)-N-nitrosourea Moieties Separated by a Three-Carbon Chain

118. Puzzles of Government Formation : Coalition Theory and Deviant Cases

119. A phase II study assessing the benefit of cisplatin re-introduction (stop and go strategy) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): The IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)

120. Weekly paclitaxel plus bevacizumab versus docetaxel as second or third-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC): Results from the phase III study IFCT-1103 ULTIMATE

121. The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways

122. The Europeanization of Domestic Legislation in Luxembourg

123. Bacterial infection profiles in lung cancer patients with febrile neutropenia

124. From coalition theory to coalition puzzles

125. Puzzles of Government Formation

126. Wild-type and mutant p53 proteins interact with mitochondrial caspase-3

127. A LEO-MSS system for position reporting and data messaging services

128. Dominant Political Parties and Democracy

129. The Selection of Ministers in Europe

131. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription

133. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells

134. Parteiensystem, politische Parteien und Wahlen

135. The tetramerization domain of p53 is required for efficient BAK oligomerization

136. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts

137. IFCT-1003 LADIE trial: Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC

138. Real-life 2-year therapeutic strategies in the management of 2003 metastatic non-small-cell lung cancers (NSCLCs) in French general hospital

139. Avant-propos

141. Delegation in Contemporary Democracies

143. Policy with or without parties? A comparative analysis of policy priorities and policy change in Belgium, 1991 to 2000

144. The codon 47 polymorphism in p53 is functionally significant

146. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex

147. The Selection of Ministers in Europe : Hiring and Firing

150. Methods to Study p53-Repressed Promoters

Catalog

Books, media, physical & digital resources